I want to let you know about some important research out of Italy. Corvelva is an Italian organization with one of the few independent labs in the world capable of analyzing vaccine contents. Corvelva’s lab analyzed Priorix Tetra – GlaxoSmithKlein’s measles, mumps, rubella, and chickenpox vaccine – which is made using the MRC-5 human fetal cell line.
Their analysis found 360,000 fetal cells in the vaccine. Researchers did a complete genome sequencing of the Priorix vaccine, and found the entire human genome sequence of a male. This is consistent with what we already know about MRC-5 being derived from the lung tissue of an aborted male at 3 1/2 months gestation. It also found high rates of abnormality in the genetic code, and 560 genes linked to cancer.
Please take a few minutes to watch this powerful video summarizing Corvelva’s research that was presented at the Italian National Biologist’s Chamber conference on January 25, 2019. Corvelva’s paper, Vaccinegate: MRC-5 Contained in Priorix Tetra – Complete Genome Sequencing, is also available on its website and provides the detailed scientific research.
For more details about Corvelva’s research, please see the following:
- Corvelva’s Press Conference in January 2019 sharing more details about their research.
- Researcher Loretta Bolgan’s presentation sharing an update on Corvelva’s analysis on September 27, 2019. While the video is in Italian, the text summary that follows is an helpful snapshot of their findings.